Whole megakaryocytes are present among CD34+ cells in the peripheral blood of patients with acute myeloid leukemia after intensive chemotherapy

Haematologica

Volumn 81, Issue 3, 1996, Pages 284-285

  Delfini, Costante ^a   Centis, Filippo ^a   Annibali, Mauro ^a  

^a SAN SALVATORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; IDARUBICIN; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; HEMATOPOIETIC STEM CELL; HUMAN; MEGAKARYOCYTE;

ACUTE DISEASE; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; LEUKEMIA, MYELOID; MEGAKARYOCYTES;

EID: 0030324207     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Efrati P, Rozenszajn L. The morphology of buffy coat in normal human adults. Blood 1960; 15:1012-9.
2. Gorius JB, Dreyfus B, Sultan C, Basch A, d'Oliveira JG. Identification of circulating micromegakaryocytes in a case of refractory anemia: an electron microscopic-cytochemical study. Blood 1972; 40:453-63.
3. Pedersen NT, Laursen B. Megakaryocytes in cubital venous blood in patients with chronic myeloproliferative diseases. Scand J Hematol 1983; 30:50-8.
4. Zauli G, Vitale L, Brunelli MA, Bagnara GP. Prevalence of the primitive megakaryocyte progenitors (BFU-Meg) in adult human peripheral blood. Exp Hematol 1992; 20:850-5.
5. Siena S, Bregni M, Bonsi L, et al. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors. Exp Hematol 1993; 21:1583-90.
6. Carlo Stella C, Cazzola M, De Fabritiis P, et al. CD34-positive cells: biology and clinical relevance. Haematologica 1995; 80:367-87.
7. Sheridan WP, Begley CG, Juttner CA, et al. Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemoterapy. Lancet 1992; 339:640-5.
8. To LB, Roberts MM, Haylock DN, et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9:277-84.
9. Debili N, Issaad C, Massé JM, et al. Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood 1992; 80:3022-35.